# FDA Inspection 1064451 - Orthority Corporation - August 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/orthority-corporation/afcf433c-d9ac-4cde-8f2b-a52a60a01f43
Source feed: FDA_Inspections

> FDA Inspection 1064451 for Orthority Corporation on August 14, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1064451
- Company Name: Orthority Corporation
- Inspection Date: 2018-08-14
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1162402 - 2022-02-08](https://www.keypedia.com/records/fda_inspections/orthority-corporation/03dc3032-f12d-4cf6-95be-15f378ba3e6b)
- [FDA Inspection 1162402 - 2022-02-08](https://www.keypedia.com/records/fda_inspections/orthority-corporation/2a93c9b8-446c-4966-9604-bcff9ae44a68)
- [FDA Inspection 935460 - 2015-07-09](https://www.keypedia.com/records/fda_inspections/orthority-corporation/73b4328d-3653-4515-a7d1-de4a1358998f)
- [FDA Inspection 774189 - 2012-03-27](https://www.keypedia.com/records/fda_inspections/orthority-corporation/5293bfa1-1847-4191-9cd8-77a322a18e73)
- [FDA Inspection 774189 - 2012-03-27](https://www.keypedia.com/records/fda_inspections/orthority-corporation/aefd06f0-b84a-450c-8db7-1ec0b85e4151)

Company: https://www.keypedia.com/companies/orthority-corporation/0ea83798-a5f6-485f-a372-39213709b24b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d